

LONDON, Oct 19 (Reuters) - Shire still hopes to launch its new dry eye drug lifitegrast next year, despite a decision by the U.S. Food and Drug Admini...


* U.S. regulator wants further lifitegrast clinical study * Shire says expects new study results before end of year * Setback for company's top drug l...


Oct 16 (Reuters) - The U.S. Food and Drug Administration notified Shire Plc it will not approve its eye drug Lifitegrast, the company said on Friday,...


(ShareCast News) - The FTSE 100 was up 28.77 points (0.45%) mid-afternoon Friday to 6,367.44 as hopes of further stimulus measures by the European Cen...